Verition Fund Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,600
Closed -$198K 2328
2025
Q4
$198K Sell
17,600
-40,134
-70% -$459K ﹤0.01% 3181
2025
Q3
$667K Sell
57,734
-45,254
-44% -$530K ﹤0.01% 2846
2025
Q2
$1.26M Sell
102,988
-30,928
-23% -$389K 0.01% 2296
2025
Q1
$1.92M Buy
133,916
+119,416
+824% +$1.86M 0.01% 1607
2024
Q4
$231K Buy
+14,500
New +$287K ﹤0.01% 2916
2024
Q2
Sell
-16,047
Closed -$319K 2982
2024
Q1
$319K Buy
+16,047
New +$310K ﹤0.01% 2264
2021
Q3
Sell
-8,296
Closed -$302K 1893
2021
Q2
$302K Buy
8,296
+3,213
+63% +$133K ﹤0.01% 1338
2021
Q1
$222K Buy
+5,083
New +$239K ﹤0.01% 1276
2018
Q4
Sell
-5,768
Closed -$395K 827
2018
Q3
$395K Buy
+5,768
New +$371K 0.01% 927
2017
Q2
Sell
-12,453
Closed -$474K 924
2017
Q1
$474K Buy
12,453
+4,571
+58% +$178K 0.04% 588
2016
Q4
$291K Buy
+7,882
New +$282K 0.03% 844
2015
Q1
Sell
-7,165
Closed -$326K 390
2014
Q4
$326K Buy
+7,165
New +$281K 0.07% 129

Other funds holding AVNS

Verition Fund Management's AVNS Position: Q1 2026 in Review

Verition Fund Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 17,600 shares — an estimated $198K sold.

Verition Fund Management first reported a position in AVNS in Q4 2014 and held it in 12 quarters. The position peaked at $1.92M in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Verition Fund Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 17,600 Avanos Medical shares in Q1 2026, an estimated $198K.
  • Verition Fund Management first reported a position in Avanos Medical in Q4 2014 and held it in 12 quarters.
  • Verition Fund Management's Avanos Medical position peaked at $1.92M in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.